Sulfatrim Pediatric (Oral)
Generic name:sulfamethoxazole and trimethoprim (oral route) [ sul-fa-meth-OX-a-zole, trye-METH-oh-prim ]
Drug class:Sulfonamides
Medically reviewed by Drugs.com. Last updated on Apr 23, 2022.
Commonly used brand name(s)
In the U.S.
- Bactrim
- Bactrim DS
- Septra
- Septra DS
- SMZ-TMP Pediatric
- Sulfatrim
- Sulfatrim Pediatric
In Canada
- Apo-Sulfatrim
- Novo-Trimel
- Nu-Cotrimox
- Septa Pediatric
- Septra Pediatric Suspension
Available Dosage Forms:
- Tablet
- Suspension
Therapeutic Class: Sulfonamide Combination
Pharmacologic Class: Folic Acid Antagonist
Chemical Class: Sulfonamide
Uses for Sulfatrim Pediatric
Sulfamethoxazole and trimethoprim combination is used to treat infections including urinary tract infections, middle ear infections (otitis media), bronchitis, traveler's diarrhea, and shigellosis (bacillary dysentery). This medicine is also used to prevent or treat Pneumocystis jiroveci pneumonia or Pneumocystis carinii pneumonia (PCP), a very serious kind of pneumonia. This type of pneumonia occurs more commonly in patients whose immune systems are not working normally, including cancer patients, transplant patients, and patients with acquired immune deficiency syndrome (AIDS).
Sulfamethoxazole and trimethoprim combination is an antibiotic. It works by eliminating the bacteria that cause many kinds of infections. This medicine will not work for colds, flu, or other virus infections.
This medicine is available only with your doctor's prescription.
Before using Sulfatrim Pediatric
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of sulfamethoxazole and trimethoprim combination in children 2 months of age and older. Because of the toxicity of the combination of sulfamethoxazole and trimethoprim, use in infants younger than 2 months of age is not recommended.
Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of sulfamethoxazole and trimethoprim combination in the elderly. However, elderly patients are more likely to have a folate deficiency, age-related kidney or liver problems, and may be more likely to experience unwanted side effects (eg, severe skin rash, increased potassium in the body, or problems with blood clotting or the immune system). There may be an adjustment in the dose for elderly patients receiving sulfamethoxazole and trimethoprim ...